PD1 plays an important role in tumorigenesis as a tumor immune escape target, and PD1 antibodies as antitumor drugs can inhibit PD1 and mitigate tumor growth and cancer development (Ribas and Wolchok, 2018). Here, PDCD1 is linked to neoplasm.